"अब कैंसर की लड़ाई जीतेगा उत्तराखण्ड " | आयुष्मान भारत योजना स्वीकृत

Patient Education & Oncology Resources

ACADEMIC EXCELLENCE

Presentations, Awards & Publications

Presentations & Awards

CEO Award
Award of Appreciation & Excellence

Awarded for research and publications by Abhay Soi, CEO of MAX Healthcare.

ESMO TAT ASIA 2025 | Hong Kong
Poster Presentation

Real-world outcomes of Trastuzumab Deruxtecan in HER2-low breast cancers (18–20 July 2025).

ESMO Grant 2025 | Hong Kong
Merit Travel Grant

Advanced drug development course by ESMO (17–18 July 2025).

ESMO GI 2024 | Munich, Germany
Poster Presentation

Trastuzumab therapy in Gallbladder Cancers (26–29 June 2024).

ONCOLOGY UPDATES 2024 | New Delhi
2nd Prize

Oncology Quiz Competition (28 April 2024).

ONCOCON 2024 | New Delhi
3rd Prize

Oncology Quiz Competition (14 April 2024).

2nd Enigma Cancer Conclave 2024 | New Delhi
2nd Prize

Oncology Quiz (6 April 2024).

9th ICHNO 2024 | Barcelona, Spain
Poster Presentation

International Congress on Head and Neck Oncology (21–23 March 2024).

3rd Indian Cancer Congress 2023 | Mumbai
Oral Paper Presentation

Presented research at ICC 2023 (2–5 November 2023).

3rd ISO Midterm Conclave 2022 | Lucknow
2nd Prize

PG Quiz Competition, Indian Society of Oncology (10 April 2022).

32nd AROI UP Chapter 2021 | Agra
1st Prize

Best Poster Presentation (Thesis) (18–19 December 2021).

Published Research Papers

2026

Chhabra R, Kartik M, Dodagoudar C, Vashishtha B, Osama MA.

Reversible 5-fluorouracil induced toxic leukoencephalopathy in a post-operative patient with gastroesophageal junction adenocarcinoma.
Int Cancer Conf J. 2026;15(4):670-4. doi:10.1007/s13691-026-00905-y
2026

Chhabra R, Shukla R, Kartika M, Dodagoudar C, Dua A, Osama MA.

Uncommon origin, evolving approach: chemo-immunotherapy in gallbladder small cell neuroendocrine carcinoma.
Trop Gastroenterol. 2026;47(3):173-6. doi:10.4103/TG.TG_20_26
2025

Chhabra R, Dodagoudar C, Rajpurohit S, Vidushi A, Kumari V, Osama MA.

Immune-related dermatologic reactions in cancer patients undergoing immunotherapy: a case series.
Indian J Med Paediatr Oncol. 2025. doi:10.1055/s-0045-1811565
2025

Chhabra R, Mittal K, Osama MA.

Complete response to teclistamab in a pentarefractory elderly patient with multiple myeloma: a real-world case report from India.
Indian J Hematol Blood Transfus. 2025. doi:10.1007/s12288-025-02189-3
2025

Ahmed MS, Chhabra R, Rajpurohit S, Patnaik N, Osama MA.

Plasmablastic lymphoma of maxilla in an immunocompetent adult.
J Maxillofac Oral Surg. 2025. doi:10.1007/s12663-025-02523-2
2025

Chhabra R, Mittal K, Tufchi A, Rajpurohit S, Mittal DK, Vidushi A, Saxena S, Osama MA.

Enteric thymic adenocarcinoma: understanding a unique pathology in the mediastinum.
Indian J Pathol Microbiol. 2025. doi:10.4103/ijpm.ijpm_1036_24
2025

Chhabra R, Rajpurohit S, Bajpai K, Singh J, Osama MA.

From skin to lung: a rare case of PDZRN3/RAF1 fusion in recurrent dermatofibrosarcoma protuberans with lung metastasis.
Indian J Thorac Cardiovasc Surg. 2025. doi:10.1007/s12055-025-01990-z
2024

Chhabra R, Ahmed MS, Dodagoudar C, Rajpurohit S, Vidushi A, Patnaik N, Osama MA.

Beyond bones: exploring primitive neuroectodermal tumor of kidney.
Indian J Surg Oncol. 2024. doi:10.1007/s13193-024-02034-5
2024

Chhabra R, Dodagoudar C, Narwariya A, Mane P, Osama MA.

Unveiling unique EWS: CREB1 gene fusion in a jejunal tumor.
Indian J Surg Oncol. 2024. doi:10.1007/s13193-024-02038-1
2024

Chhabra R, Vidushi A, Rajpurohit S, Singh J, Osama MA.

Spontaneous tumor lysis syndrome in a case of hepatocellular carcinoma with sarcomatoid differentiation.
Indian J Surg Oncol. 2024;15(2):370–374. doi:10.1007/s13193-024-01895-0
2022

Chhabra R, Misra S, Prasad P, Khati S.

Meningeal melanocytoma–a clinicohistological masquerader.
Neurol India. 2022 Sep–Oct;70(5):2153–2155. doi:10.4103/0028-3886.359256
PATIENT SUPPORT

Frequently Asked Questions

Find clear answers to common questions about cancer treatments, OPD timings, and insurance coverage.

Dr. Raja Chhabra is available at Park Hospitals, Rudrapur (Delhi-Nainital Highway) from Monday to Wednesday and on Saturday (10:00 AM – 05:00 PM). Special consultation and OPD sessions are also conducted for patients in Haldwani (Thu–Fri).

Yes! Park Hospitals is fully empaneled under the Ayushman Bharat Scheme. Eligible patients can receive approved cancer treatments, chemotherapy, and supportive care packages under the scheme. You can bring your Ayushman card during your consultation for verification.

You can book an appointment directly through our website booking form, or call our direct emergency & helpline number at +91 8851518865. You can also connect via WhatsApp using the floating chat widget on the bottom left.

For your first visit, please bring all previous medical records, biopsy/histopathology reports, blood test results, imaging scans (CT/MRI/PET scans), a valid government ID, and your Ayushman Bharat card (if applicable).

We offer comprehensive medical oncology services including personalized Chemotherapy, Targeted Therapy, Immunotherapy, Precision Oncology based on molecular profiling, and palliative/supportive care for various malignancies.
WhatsApp Chat Call Hospital